178 related articles for article (PubMed ID: 25166282)
21. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process.
Lin Q; Huang Q; Li C; Bao C; Liu Z; Li F; Zhu L
J Am Chem Soc; 2010 Aug; 132(31):10645-7. PubMed ID: 20681684
[TBL] [Abstract][Full Text] [Related]
22. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
23. Investigation of in vitro permeability and in vivo pharmacokinetic behavior of bare and functionalized MCM-41 and MCM-48 mesoporous silica nanoparticles: a burst and controlled drug release system for raloxifene.
Shah P; Rajput SJ
Drug Dev Ind Pharm; 2019 Apr; 45(4):587-602. PubMed ID: 30633575
[TBL] [Abstract][Full Text] [Related]
24. Curcumin-encapsulated MePEG/PCL diblock copolymeric micelles: a novel controlled delivery vehicle for cancer therapy.
Mohanty C; Acharya S; Mohanty AK; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2010 Apr; 5(3):433-49. PubMed ID: 20394536
[TBL] [Abstract][Full Text] [Related]
25. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
Manju S; Sreenivasan K
J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
[TBL] [Abstract][Full Text] [Related]
26. Development of surface curcumin nanoparticles modified with biological macromolecules for anti-tumor effects.
Choi JS
Int J Biol Macromol; 2016 Nov; 92():850-859. PubMed ID: 27481341
[TBL] [Abstract][Full Text] [Related]
27. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.
Lu Y; Ding N; Yang C; Huang L; Liu J; Xiang G
J Liposome Res; 2012 Jun; 22(2):110-9. PubMed ID: 22372871
[TBL] [Abstract][Full Text] [Related]
28. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
[TBL] [Abstract][Full Text] [Related]
29. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
Lu J; Liong M; Zink JI; Tamanoi F
Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
[No Abstract] [Full Text] [Related]
30. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials.
Tao Z; Toms BB; Goodisman J; Asefa T
Chem Res Toxicol; 2009 Nov; 22(11):1869-80. PubMed ID: 19817448
[TBL] [Abstract][Full Text] [Related]
31. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
32. Mesoporous silica size, charge, and hydrophobicity affect the loading and releasing performance of lambda-cyhalothrin.
Xiao S; Shoaib A; Xu J; Lin D
Sci Total Environ; 2022 Jul; 831():154914. PubMed ID: 35364147
[TBL] [Abstract][Full Text] [Related]
33. Efficient intracellular delivery of camptothecin by silica/titania hollow nanoparticles.
Kim C; Kim S; Oh WK; Choi M; Jang J
Chemistry; 2012 Apr; 18(16):4902-8. PubMed ID: 22422377
[TBL] [Abstract][Full Text] [Related]
34. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles.
Liu Q; Zhang J; Xia W; Gu H
Nanoscale; 2012 Jun; 4(11):3415-21. PubMed ID: 22543531
[TBL] [Abstract][Full Text] [Related]
35. Isomer-dependent adsorption and release of cis- and trans-platin anticancer drugs by mesoporous silica nanoparticles.
Tao Z; Xie Y; Goodisman J; Asefa T
Langmuir; 2010 Jun; 26(11):8914-24. PubMed ID: 20148511
[TBL] [Abstract][Full Text] [Related]
36. Chitosan nanoparticles for lipophilic anticancer drug delivery: Development, characterization and in vitro studies on HT29 cancer cells.
Abruzzo A; Zuccheri G; Belluti F; Provenzano S; Verardi L; Bigucci F; Cerchiara T; Luppi B; Calonghi N
Colloids Surf B Biointerfaces; 2016 Sep; 145():362-372. PubMed ID: 27214786
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of mesoporous silica nanomaterials.
Di Pasqua AJ; Sharma KK; Shi YL; Toms BB; Ouellette W; Dabrowiak JC; Asefa T
J Inorg Biochem; 2008 Jul; 102(7):1416-23. PubMed ID: 18279965
[TBL] [Abstract][Full Text] [Related]
38. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
[TBL] [Abstract][Full Text] [Related]
39. Functional silica nanoparticles for redox-triggered drug/ssDNA co-delivery.
Ma X; Nguyen KT; Borah P; Ang CY; Zhao Y
Adv Healthc Mater; 2012 Nov; 1(6):690-7. PubMed ID: 23184818
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents.
Liu Y; Mi Y; Zhao J; Feng SS
Int J Pharm; 2011 Dec; 421(2):370-8. PubMed ID: 22001536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
